LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation

Journal of Neurology

Volumn 260, Issue 11, 2013, Pages 2884-2889

  Gao, Chao ^a   Pang, Hao ^a   Luo, Xiao Guang ^a   Ren, Yan ^a   Shang, Hong ^a   He, Zhi Yi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

G2385R variant; Gender effects; LRRK2; Motor complication; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; LEVODOPA;

ADULT; ARTICLE; BLOOD SAMPLING; CHINESE; CLINICAL FEATURE; CLINICAL STUDY; COGNITION; DAILY LIFE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; DYSKINESIA; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; ONSET AGE; PARKINSON DISEASE; PHENOTYPE; POPULATION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION; UNIFIED PARKINSON DISEASE RATING SCALE; WILD TYPE;

AGED; FEMALE; GENOTYPE; GLYCINE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; SERINE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84889564576     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-7086-9     Document Type: Article

References (26)

1. Lubbe S, Morris HR (2013) Recent advances in Parkinson's disease genetics. J Neurol
2. Fung HC, Chen CM, Hardy J, Singleton AB, Wu YR (2006) A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan. BMC Neurol 6:47
3. Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohe CF, Chang HC, Chen RS, Weng YH, Vanacore N, Breedveld GJ, Oostra BA, Bonifati V (2006) A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 7(3):133-138
4. Tan EK, Zhao Y, Skipper L, Tan MG, Di Fonzo A, Sun L, Fook-Chong S, Tang S, Chua E, Yuen Y, Tan L, Pavanni R, Wong MC, Kolatkar P, Lu CS, Bonifati V, Liu JJ (2007) The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum Genet 120(6):857-863
5. Li C, Ting Z, Qin X, Ying W, Li B, Guo Qiang L, Jian Fang M, Jing Z, Jian Qing D, Di Sheng C (2007) The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease. Mov Disord 22(16):2439-2443
6. An XK, Peng R, Li T, Burgunder JM, Wu Y, Chen WJ, Zhang JH, Wang YC, Xu YM, Gou YR, Yuan GG, Zhang ZJ (2008) LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China. Eur J Neurol 15(3):301-305
7. Zabetian CP, Yamamoto M, Lopez AN, Ujike H, Mata IF, Izumi Y, Kaji R, Maruyama H, Morino H, Oda M, Hutter CM, Edwards KL, Schellenberg GD, Tsuang DW, Yearout D, Larson EB, Kawakami H (2009) LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Mov Disord 24(7):1034-1041
8. Choi JM, Woo MS, Ma HI, Kang SY, Sung YH, Yong SW, Chung SJ, Kim JS, Shin HW, Lyoo CH, Lee PH, Baik JS, Kim SJ, Park MY, Sohn YH, Kim JH, Kim JW, Lee MS, Lee MC, Kim DH, Kim YJ (2008) Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease. Neurogenetics 9(4):263-269
9. Farrer MJ, Stone JT, Lin CH, Dachsel JC, Hulihan MM, Haugarvoll K, Ross OA, Wu RM (2007) Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord 13(2):89-92
10. Haas BR, Stewart TH, Zhang J (2012) Premotor biomarkers for Parkinson's disease - a promising direction of research. Transl Neurodegener 1(1):11
11. Hassin-Baer S, Laitman Y, Azizi E, Molchadski I, Galore-Haskel G, Barak F, Cohen OS, Friedman E (2009) The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel. J Neurol 256(3):483-487
12. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181-184
13. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I et al (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40(10):1529-1534
14. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, Macphee G, Macmahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AH (2007) The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 22(13):1901-1911
15. Kim JM, Lee JY, Kim HJ, Kim JS, Shin ES, Cho JH, Park SS, Jeon BS (2010) The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population. Parkinsonism Relat Disord 16(2):85-88
16. Fu X, Zheng Y, Hong H, He Y, Zhou S, Guo C, Liu Y, Xian W, Zeng J, Li J, Liu Z, Chen L, Pei Z (2013) LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland China. Parkinsonism Relat Disord 19(3):397-398
17. Haubenberger D, Bonelli S, Hotzy C, Leitner P, Lichtner P, Samal D, Katzenschlager R, Djamshidian A, Brucke T, Steffelbauer M, Bancher C, Grossmann J, Ransmayr G, Strom TM, Meitinger T, Gasser T, Auff E, Zimprich A (2007) A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease. Mov Disord 22(11):1640-1643
18. Chan DK, Ng PW, Mok V, Yeung J, Fang ZM, Clarke R, Leung E, Wong L (2008) LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients. J Neural Transm 115(9):1275-1277
19. Tan EK, Zhao Y, Tan L, Lim HQ, Lee J, Yuen Y, Pavanni R, Wong MC, Fook-Chong S, Liu JJ (2007) Analysis of LRRK2 Gly2385Arg genetic variant in non-Chinese Asians. Mov Disord 22(12):1816-1818
20. Cai J, Lin Y, Chen W, Lin Q, Cai B, Wang N, Zheng W (2013) Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China. Neurol Sci
21. Tan EK, Peng R, Wu YR, Wu RM, Wu-Chou YH, Tan LC, An XK, Chen CM, Fook-Chong S, Lu CS (2009) LRRK2 G2385R modulates age at onset in Parkinson's disease: a multi-center pooled analysis. Am J Med Genet B Neuropsychiatr Genet 150B(7):1022-1023
22. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ 3rd (2008) Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 70(3):200-209
23. Saunders-Pullman R (2003) Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both? Endocrine 21(1):81-87
24. Ascherio A, Weisskopf MG, O'Reilly EJ, McCullough ML, Calle EE, Rodriguez C, Thun MJ (2004) Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol 160(10):977-984
25. Ascherio A, Chen H, Schwarzschild MA, Zhang SM, Colditz GA, Speizer FE (2003) Caffeine, postmenopausal estrogen, and risk of Parkinson's disease. Neurology 60(5):790-795
26. Simon KC, Chen H, Gao X, Schwarzschild MA, Ascherio A (2009) Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease. Mov Disord 24(9):1359-1365